Zener Engineering Services Ltd (ZES)
provided pharma validation services, whilst working closely with former FDA and MHRA inspectors to ensure pharmaceutical facilities had reached the required standard for their first inspection.
Implementing quality systems which comply with current regulatory requirements and cGMP is an area of ZES expertise.
Pharmaceutical validation services by an FDA MHRA EMA experienced validation consultant or pharmaceutical engineer, for GMP manufacturing operations.
Zener Engineering Services Ltd (ZES)
provided pharma validation services, whilst working closely with former FDA and MHRA inspectors to ensure pharmaceutical facilities had reached the required standard for their first inspection.
Implementing quality systems which comply with current regulatory requirements and cGMP is an area of ZES expertise.
Pharmaceutical validation services by an FDA MHRA EMA experienced validation consultant or pharmaceutical engineer, for GMP manufacturing operations.
Zener Engineering Services Ltd (ZES)
provided pharma validation services, whilst working closely with former FDA and MHRA inspectors to ensure pharmaceutical facilities had reached the required standard for their first inspection.
Implementing quality systems which comply with current regulatory requirements and cGMP is an area of ZES expertise.
Pharmaceutical validation services by an FDA MHRA EMA experienced validation consultant or pharmaceutical engineer, for GMP manufacturing operations.
The Food and Drug Administration (FDA)
The Medicines and Healthcare products Regulatory Agency (MHRA)
The European Medicines Agency (EMA)
The Food and Drug Administration (FDA) is an agency of the United States Department of Health and Human Services. The FDA are one of the United States federal executive departments, responsible for protecting and promoting public health. They regulate and supervise food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, bio-pharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics.
ZES have worked
with former FDA Inspectors to achieve inspection success.
Zener Engineering Services Ltd (ZES) have worked closely with FDA, MHRA and EMA inspectors to ensure GxP Facilities, IT Infrastructure, Process Equipment and Computer Systems have reached the required standard for their first inspection and inspections beyond.
Implementing quality systems, which comply with current regulatory requirements and cGxP, is an area of ZES expertise.
The Medicines and Healthcare products Regulatory Agency (MHRA) was set up in April 2003 from a merger of the Medicines Control Agency and the Medical Devices Agency. The MHRA is the government agency, which is responsible for ensuring that medicines and medical devices work and are acceptably safe. The MHRA is an executive agency of the Department of Health for the UK.
The MHRA regulate a wide range of materials from medicines and medical devices to blood and therapeutic products/services that are derived from tissue engineering.
The European Medicines Agency (EMA) coordinates inspections to verify compliance to European Regulatory standards and plays a key role in harmonising GMP activities at European Union (EU) level. Any manufacturer of medicines intended for the EU market, no matter where in the world it is located, must comply with EU GMP.
The Agency coordinates GMP inspections of manufacturing sites for medicines whose marketing authorisation in the EU is submitted through the centralised procedure or as part of a referral procedure.
The Agency also plays a key role in coordinating and harmonising GMP activities at an EU level. It is involved in:
Three legal instruments lay down the principles and guidelines of GMP in the EU:
If you need help in achieving inspection success, ZES have EMA experience.
In response to the recent urgent need for the fast development of health products in the treatment of COVID-19, the World Health Organization (WHO) are in the process of developing a Good Manufacturing Practice (GMP) document. The GMP document will address the manufacturing of developmental batches, pilot batches and the sequential stability data. Data which is normally submitted as part of product applications (dossiers) for marketing authorization and the prequalification of medical products.
ZES have significant experience of, and expertise in, the following pharmaceutical engineering / manufacturing aspects:
For more information regarding our pharmaceutical services, contact ZES.
ZES have significant experience of, and expertise in, the following pharmaceutical engineering / manufacturing aspects:
For more information regarding our pharmaceutical services, contact ZES.
ZES have significant experience of, and expertise in, the following pharmaceutical engineering / manufacturing aspects:
For more information regarding our pharmaceutical services, contact ZES.
Cell and Gene Therapy (CGTs) companies are transforming the discovery of new therapies to fight disease. The CGT approach to new therapy discovery produces a relatively new category of medicine, the full potential of which has not yet been fully realised.
CGTs are different from usual chemical pharmaceuticals in that they involve extracting living cells, proteins or genetic material (DNA) from a patient, which are then altered in some way to provide a highly personalised therapy. This personalised therapy is then injected back into the patient. In some quarters it is suggested that CGTs may offer longer-lasting benefits than those provided by traditional chemical medicines.
Research into CGTs shows that they have the potential to treat often complex diseases, where no effective treatments are available from traditional chemical pharmaceuticals.
ZES continue to help CGTs along their product development journey and have a strong track record of working in the sector. ZES work to solve problems and accelerate successful GMP outcomes that generate health for our clients' patients. These activities include, but are not limited to:
Cell and Gene Therapy (CGTs) companies are transforming the discovery of new therapies to fight disease. The CGT approach to new therapy discovery produces a relatively new category of medicine, the full potential of which has not yet been fully realised.
CGTs are different from usual chemical pharmaceuticals in that they involve extracting living cells, proteins or genetic material (DNA) from a patient, which are then altered in some way to provide a highly personalised therapy. This personalised therapy is then injected back into the patient. In some quarters it is suggested that CGTs may offer longer-lasting benefits than those provided by traditional chemical medicines.
Research into CGTs shows that they have the potential to treat often complex diseases, where no effective treatments are available from traditional chemical pharmaceuticals.
ZES continue to help CGTs along their product development journey and have a strong track record of working in the sector. ZES work to solve problems and accelerate successful GMP outcomes that generate health for our clients' patients.
These activities include, but are not limited to:
"I worked with David [of Zener Engineering Services] on a project to deliver an ABB 800XA DCS system for a Blue Chip Pharmaceutical company. He was the QA lead for the supplier.
We jointly reviewed and approved a very large FAT document set in lieu of a reduced SAT and OQ. David's approach is very professional, critical, but crucially pragmatic.
I enjoyed working with him and would welcome any future opportunities to do so."
Steve Del-Bianco
Computer Systems Validation Analyst
GlaxoSmithKline GMS WARE
"I worked with David [of Zener Engineering Services] on a project to deliver an ABB 800XA DCS system for a Blue Chip Pharmaceutical company. He was the QA lead for the supplier.
We jointly reviewed and approved a very large FAT document set in lieu of a reduced SAT and OQ. David's approach is very professional, critical, but crucially pragmatic.
I enjoyed working with him and would welcome any future opportunities to do so."
Steve Del-Bianco
Computer Systems Validation Analyst
GlaxoSmithKline GMS WARE
"I briefly worked with David of Zener Engineering Services, when he was engaged as a validation manager.
David is an accomplished validation engineer and works to a high standard expected within the regulated environment.
I would have no hesitation in recommending him to anyone seeking a highly experienced engineering professional who knows his subject matter very well."
"I briefly worked with David of Zener Engineering Services, when he was engaged as a validation manager.
David is an accomplished validation engineer and works to a high standard expected within the regulated environment.
I would have no hesitation in recommending him to anyone seeking a highly experienced engineering professional who knows his subject matter very well."
ZES have worked closely with FDA and MHRA inspectors.
Ensuring pharmaceutical manufacturing facilities
have reached the required standard for their first inspection,
with the implementation of quality systems
which take into account cGMP.
Contact ZES for expert help with all
aspects of Pharmaceutical Manufacturing.
ZES have worked closely with FDA and MHRA inspectors. Ensuring pharmaceutical manufacturing facilities have reached the required standard for their first inspection,
with the implementation of quality systems which take into account cGMP.
Contact ZES for expert help with all aspects of Pharmaceutical Manufacturing.
ZES have worked closely with FDA and MHRA inspectors. Ensuring pharmaceutical manufacturing facilities have reached the required standard for their first inspection, with the implementation of quality systems which take into account cGMP.
Contact ZES for expert help
with all aspects of
Pharmaceutical Manufacturing.
Registered Office:
Rutherford House,
Warrington Road,
Birchwood,
Warrington, WA3 6ZH
United Kingdom.
Regional Office:
NETPark Plexus 2,
Thomas Wright Way,
Sedgefield, TS21 3FD
United Kingdom.
Contact Us:
Tel: (+44) 0843 5236 320 (Industry)
Tel: (+44) 0843 5236 325 (NHS)
Calls Cost 7p per min
Registered Office:
Rutherford House,
Warrington Road,
Birchwood,
Warrington,
England, WA3 6ZH
United Kingdom.
Regional Office:
NETPark Plexus 2,
Thomas Wright Way, Sedgefield, TS21 3FD
United Kingdom.
Contact Us
Tel: (+44) 0843 5236 320 (Industry)
Tel: (+44) 0843 5236 325 (NHS)
Calls Cost 7p per min
Website designed, constructed and maintained in-house by Zener Engineering Services Ltd. All rights reserved.